Market Cap (In USD)
50.00
Revenue (In USD)
2.66 Million
Net Income (In USD)
-53.73 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-1.0E-5
- PE
- -
- EPS
- -
- Beta Value
- -0.166
- ISIN
- US00511R8549
- CUSIP
- 00511R854
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. William I. Ramage D.Phil
- Employee Count
- -
- Website
- https://www.acusphere.com
- Ipo Date
- 2003-10-08
- Details
- Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
More Stocks
-
MDP
-
BIOSBioSenic S.A.
BIOS
-
ELDN
-
EASTW-R
-
YTEN
-
FLTCFFiltronic plc
FLTCF
-
023000SAMWONSTEEL Co.,Ltd.
023000
-
002382Blue Sail Medical Co.,Ltd.
002382